CTRI/2017/09/009606
Completed
未知
Evaluation of the effect of a standardized aqueous extract of Emblica officinalis on endothelial dysfunction and biomarkers of oxidative stress in metabolic syndrome subjects.
CGayatri Devi0 sites59 target enrollmentTBD
Overview
- Phase
- 未知
- Intervention
- Not specified
- Conditions
- Health Condition 1: null- Metabolic syndrome
- Sponsor
- CGayatri Devi
- Enrollment
- 59
- Status
- Completed
- Last Updated
- 4 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- •Patients were of either gender, aged 30\-68 years, having endothelial dysfunction defined as \<\= 6% change in reflection index (RI) on post salbutamol challenge test and having metabolic syndrome.
Exclusion Criteria
- •Patients with severe uncontrolled hypertension, uncontrolled hyperglycemia, impaired hepatic or renal function, cardiac arrhythmia, history of smoking, chronic alcoholism, malignancy or stroke, any other serious disease requiring active treatment and treatment with any other herbal supplements
Outcomes
Primary Outcomes
Not specified
Similar Trials
Recruiting
Phase 2
Investigating the effect of using probiotic supplements in patients with moderate to severe chronic periodontitisModerate to severe chronic periodontitis.Chronic periodontitisK05.3IRCT20240614062134N1Birjand University of Medical Sciences38
Recruiting
Phase 2
Evaluating the effects of rosemary capsule as adjunctive treatment in major depressive disordermajor depressive disorder.Mood disorder due to known physiological condition with major depressive-like episodeF06.32IRCT20110310006026N11Kerman University of Medical Sciences44
Recruiting
Phase 3
The effect ofTribulus on kidney stoneskidney stone.IRCT20240513061783N1Birjand University of Medical Sciences40
Completed
Phase 2
Assesment of the effect of supplemental aqueous extracts of Achillea milefolium in Multiple sclerosis patientsIRCT2013121915863N1Rafsanjan University of Medical Sciences75
Recruiting
Phase 2
Evaluating the effects of standardized hydroalcoholic extract of marmotti (Salvia mirzayanii Rech. f. & Esfand) capsule as adjunctive treatment in patient with helicobacter pylori infectioHelicobacter pylori.Helicobacter pylori [H. pylori] as the cause of diseases classified elsewhereB96.81IRCT20110310006026N9Kerman University of Medical Sciences66